UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis

Journal of Nuclear Medicine, 2017-10, Vol.58 (10), p.1646-1651

2017

Volltextzugriff (PDF)

Impact of natalizumab on chronic active lesions (P11-3.011)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

A Combined Lesion Distribution Parameter Predicts Disease Progression in Multiple Sclerosis (S26.005)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Serum Neurofilament Light Associates with Microglial Activation in the Multiple Sclerosis Brain (S26.010)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Phenotyping Of Multiple Sclerosis Lesions According To Innate Immune Cell Activation Using TSPO-PET (S26.003)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

TSPO-PET-measurable Microglial Activation Associates with Serum 3-hydroxykynurenine Levels in Multiple Sclerosis Patients (P14-4.007)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report

Journal of neurology, 2023-04, Vol.270 (4), p.2329-2332

2023

Volltextzugriff (PDF)

Sex comparison of white blood cell responses to acute vigorous-intensity aerobic exercise

Acta Physiologica, 2023, Vol.239 (S728), p.44

2023

Volltextzugriff (PDF)

Longitudinal stability of progression‐related microglial activity during teriflunomide treatment in patients with multiple sclerosis

European journal of neurology, 2023-08, Vol.30 (8), p.2365-2375

2023

Volltextzugriff (PDF)

Natalizumab Treatment of Multiple Sclerosis Leads to Diminished Microglial Activation in the Normal Appearing White Matter (P3.390)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI

Multiple sclerosis and related disorders, 2021-05, Vol.50, p.102810-102810

2021

Volltextzugriff (PDF)

Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland

Multiple sclerosis and related disorders, 2020-05, Vol.40, p.101980, Article 101980

2020

Volltextzugriff (PDF)

Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy

European journal of clinical microbiology & infectious diseases, 2024-04, Vol.43 (4), p.723-734

2024

Volltextzugriff (PDF)

Whole Brain Adiabatic T 1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings

Journal of magnetic resonance imaging, 2021-09, Vol.54 (3)

2021

Volltextzugriff (PDF)

Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET

Brain communications, 2022-02, Vol.4 (1), p.fcab301-fcab301

2022

Volltextzugriff (PDF)

Whole Brain Adiabatic T 1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings

Journal of magnetic resonance imaging, 2021-09, Vol.54 (3), p.866-879

2021

Volltextzugriff (PDF)

Whole Brain Adiabatic T1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings

Journal of magnetic resonance imaging, 2021-09, Vol.54 (3), p.866-879

2021

Volltextzugriff (PDF)

Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2022-07, Vol.9 (4)

2022

Volltextzugriff (PDF)

TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2023-09, Vol.10 (5)

2023

Volltextzugriff (PDF)

Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients

Multiple sclerosis and related disorders, 2022-03, Vol.59, p.103667-103667, Article 103667

2022

Volltextzugriff (PDF)

High serum neurofilament associates with diffuse white matter damage in MS

Neurology : neuroimmunology & neuroinflammation, 2021-01, Vol.8 (1)

2021

Volltextzugriff (PDF)

Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study

Multiple sclerosis and related disorders, 2021-02, Vol.48, p.102690-102690, Article 102690

2021

Volltextzugriff (PDF)

Natalizumab treatment reduces microglial activation in the white matter of the MS brain

Neurology : neuroimmunology & neuroinflammation, 2019-07, Vol.6 (4), p.e574-e574

2019

Volltextzugriff (PDF)

Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis

Multiple sclerosis and related disorders, 2021-05, Vol.50, p.102810, Article 102810

2021

Volltextzugriff (PDF)

Microglial activation, white matter tract damage, and disability in MS

Neurology : neuroimmunology & neuroinflammation, 2018-05, Vol.5 (3), p.e443-e443

2018

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)
Berichte
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Clinical Neurology
(13)
Neurosciences & Neurology
(13)
Multiple Sclerosis
(11)
Humans
(10)
Neurosciences
(9)
Middle Aged
(7)
Magnetic Resonance Imaging
(6)
Adult
(5)
Female
(5)
Male
(5)
Multiple Sclerosis - Diagnostic Imaging
(5)
Brain - Diagnostic Imaging
(4)
Diffusion Tensor Imaging
(4)
Microglia
(4)
Substantia Alba
(4)
White Matter - Diagnostic Imaging
(4)
Aged
(3)
Cell Activation
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis

Impact of natalizumab on chronic active lesions (P11-3.011)

A Combined Lesion Distribution Parameter Predicts Disease Progression in Multiple Sclerosis (S26.005)

Serum Neurofilament Light Associates with Microglial Activation in the Multiple Sclerosis Brain (S26.010)

Phenotyping Of Multiple Sclerosis Lesions According To Innate Immune Cell Activation Using TSPO-PET (S26.003)

TSPO-PET-measurable Microglial Activation Associates with Serum 3-hydroxykynurenine Levels in Multiple Sclerosis Patients (P14-4.007)

PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report

Sex comparison of white blood cell responses to acute vigorous-intensity aerobic exercise

Longitudinal stability of progression‐related microglial activity during teriflunomide treatment in patients with multiple sclerosis

Natalizumab Treatment of Multiple Sclerosis Leads to Diminished Microglial Activation in the Normal Appearing White Matter (P3.390)

Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI

Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland

Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy

Whole Brain Adiabatic T 1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings

Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET

Whole Brain Adiabatic T 1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings

Whole Brain Adiabatic T1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings

Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis

TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis

Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients

High serum neurofilament associates with diffuse white matter damage in MS

Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study

Natalizumab treatment reduces microglial activation in the white matter of the MS brain

Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis

Microglial activation, white matter tract damage, and disability in MS

Suchergebnisse filtern